Thus, CAIX is not only a prognostic biomarker but also a cancer-specific marker, although it can be expressed in normal tissues as well, including the gastric mucosa, large bile duct and pancreas.[15] Carbonic anhydrase IX-targeting therapy could be useful as a novel strategy for advanced RCC. Here, CA9 is linked to cancer.